Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride in early stage prostate cancer
NCT00985738Phase 2Terminated
- Sponsor
- University of Colorado Denver
- Start
- Sep 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Dutasteride Arm with Placebo Arm (2 arms). Primary endpoints: Effect of Short-term Intake of Daily Dutasteride on Prostate Cancer Volume at 24 months, Effect of Short-term Intake of Daily Dutasteride on Distribution Within the Gland at 24 months and 1 more. Started Sep 2009; status: terminated.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00985738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985738.